Andréasson, Mattias
Solders, Göran
Björkvall, Cecilia K.
Machaczka, Maciej
Svenningsson, Per
Funding for this research was provided by:
The study was funded by the collaboration agreement between Karolinska Institutet and Stockholm County Council (ALF). Per Svenningsson is a Wallenberg Clinical Scholar.
Article History
Received: 19 June 2019
Accepted: 10 October 2019
First Online: 25 October 2019
Competing interests
: M.M., P.S. and C.K.B. have received honoraria for lecturing on Gaucher disease from Sanofi-Genzyme and Shire/Takeda. M.A. and P.S. are investigators in the MOVES-PD study sponsored by Sanofi-Genzyme. The other authors declare that they have no competing interests.